Related Experiment Videos
[Postvaricella purpura fulminans]
L Alsina Manrique de Lara1, S Zambudio Sert, A Pizà Oliveras
1Sección de Urgencias, Servicio de Pediatría, Hospital Sant Joan de Déu-Clínic, Universitat de Barcelona, Paseo Sant Joan de Déu, 08950 Esplugues de Llobregat, Barcelona, Spain. cluaces@hsjdbcn.org
Anales De Pediatria (Barcelona, Spain : 2003)
|June 23, 2004
Summary
Purpura fulminans (PF) is a rare varicella complication causing skin lesions and blood clotting issues. This study explores its characteristics, diagnosis, and treatment, focusing on protein S deficiency.
Area of Science:
- Hematology
- Immunology
- Pediatrics
Background:
- Purpura fulminans (PF) is a rare but severe complication of varicella (chickenpox).
- It involves progressive purpuric or ecchymotic lesions and consumption coagulopathy.
- The underlying mechanism involves a decrease in protein S, likely due to autoantibodies.
Observation:
- Presents three cases of post-varicella PF.
- Details clinical and biochemical features of the condition.
- Highlights the role of protein S deficiency and autoantibody formation.
Findings:
- Coagulation activation in PF is linked to low protein S levels.
- Antiprotein S antibodies are implicated, though their synthesis mechanism is unclear.
- The study reviews diagnostic and therapeutic strategies for post-varicella PF.
Implications:
- Understanding PF pathogenesis is crucial for timely diagnosis and management.
- Further research into autoantibody production may reveal new therapeutic targets.
- This review provides current recommendations for managing this rare varicella complication.